LG Chem: all 184 studies

Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.

• OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLCNot yet recruitingNCT07888075Phase 2/3
• A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C MutationNot yet recruitingNCT07752875Phase 1/2
• A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious PubertyRecruitingNCT07710430Phase 4
• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
• Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCRecruitingNCT06332755Phase 1
• Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil CapsuleRecruitingNCT06206135
• A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaRecruitingNCT06064877Phase 3
• A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic ObesityNot yet recruitingNCT06041841Phase 2
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
• A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaRecruitingNCT05865535Phase 1
• Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in ChildrenRecruitingNCT01604395
• A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With HyperuricemiaCompletedNCT03934099Phase 2Results posted
• Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane in Nasolabial Fold Intradermal InjectionCompletedNCT03738020Not applicableResults posted
• Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume sCompletedNCT02661737Results posted
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC)CompletedNCT02627963Phase 3Results posted
• Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Menopur® Inj.CompletedNCT02458768Phase 4Results posted
• A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabial Fold InjectionCompletedNCT02340091Not applicableResults posted
• A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Fold InjectionCompletedNCT02340078Not applicableResults posted
• Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic sCompletedNCT02334358Results posted
• A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive LabelTerminatedNCT02318368Phase 2Results posted
• Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and HyperlipidemiaCompletedNCT01918332Phase 3Results posted
• Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast CancerTerminatedNCT01745367Phase 2Results posted
• A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCCTerminatedNCT01673386Phase 2Results posted
• Study of LC23-1306 in Healthy Male SubjectsCompletedNCT01526577Phase 1Results posted
• A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line TherapyCompletedNCT01478594Phase 2Results posted
• A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib ProtocolsTerminatedNCT01369433Not applicableResults posted
• A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell CarcinomaCompletedNCT01297244Phase 2Results posted
• An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).CompletedNCT01076010Phase 3Results posted
• A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell CarcinomaCompletedNCT01030783Phase 3Results posted
• A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell CarcinomaCompletedNCT00502307Phase 2Results posted
• A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting.CompletedNCT07399470Phase 1
• The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy VolunteersCompletedNCT07396844Phase 1
• A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a MealCompletedNCT07333742Phase 1
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/3
• Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).Active, not recruitingNCT06921395Phase 4
• A Study to Compare Eutropin Formulations in Healthy Volunteers for Bioavailability, Safety, and TolerabilityCompletedNCT06743997Phase 1
• Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus PatientsCompletedNCT06495281
• A Study of LC542019 in Healthy Subjects and Subjects With T2DMCompletedNCT06333977Phase 1
• Effect of Tigulixostat on the Pharmacokinetics of TheophyllineCompletedNCT06189404Phase 1
• A First in Human Study to Assess the Safety, Tolerability of LB54640 in in Healthy Overweight and Obese SubjectsCompletedNCT06040372Phase 1
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout PatientsCompletedNCT05586971Phase 3
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout PatientsCompletedNCT05586958Phase 3
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/3
• Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in InfantsCompletedNCT05431933Phase 3
• Clinical Investigation of YVOIRE Y-Solution 360 for Lip Augmentation in ChinaCompletedNCT05314504Not applicable
• Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes MellitusStatus unknownNCT05281029
• A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of LG00034053 in Patients With Knee OACompletedNCT05237752Phase 1/2
• Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo TransferCompletedNCT05130125
• A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial FoldsCompletedNCT05106751Phase 4
• Food-effect Bioavailability of Gemigliptin and Dapagliflozin 50/10 mgStatus unknownNCT05105698Phase 1
• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaCompletedNCT04987203Phase 3
• Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female SubjectsCompletedNCT04966325Early Phase 1
• Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline ContouringCompletedNCT04886544Not applicable
• Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy AdultsCompletedNCT04886050Phase 1
• Effectiveness and Safety of YVOIRE Y-Solution 540CompletedNCT04855188Not applicable
• A Phase 1 Study of AV-380 in Healthy SubjectsCompletedNCT04815551Phase 1
• To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face VolumeCompletedNCT04784299Not applicable
• A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.CompletedNCT04738019
• To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in EuropeCompletedNCT04732793Not applicable
• A Phase I Clinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of TT-01025-CL in Healthy SubjectsStatus unknownNCT04730050Phase 1
• Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mgStatus unknownNCT04544319Phase 1
• To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-FaceCompletedNCT04437745Not applicable
• To Evaluate Safety and Effectiveness of RovatitanTab.Status unknownNCT04398771
• Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the KneeCompletedNCT04369261
• Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy SubjectsCompletedNCT04360343Phase 1
• Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.CompletedNCT04317703Phase 1
• To Evaluate the Performance and Safety of YVOIRE Y Solution 360 Versus Comparator for Lips and Perioral Area.TerminatedNCT04299295Not applicable
• A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin AloneStatus unknownNCT04255238Phase 3
• Observational Study to Develop Dosing ChartCompletedNCT04227171
• The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy AdultsCompletedNCT04139824Phase 1
• A Study of YVOIRE Y-Solution 360 for Hand Augmentation to Correct Volume LossTerminatedNCT04112017Not applicable
• A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid LeukemiaWithdrawnNCT04100330Phase 2
• Efficacy and Safety of LC51-0255 in Subjects With Ulcerative ColitisWithdrawnNCT04096573Phase 2
• 6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy VolunteersCompletedNCT04085224Phase 1
• Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
• Mass Balance Study of [14C]LC350189 in Healthy VolunteersCompletedNCT04070846Phase 1
• Food-effect Bioavailability of Fixed Dose Combination Zemimet® SR Tab. 50/1000 mg Under Fed and Fasting ConditionsStatus unknownNCT04070794Phase 1
• Renal PK Study of LC350189CompletedNCT04066712Phase 1
• A Phase IV Study to Assess the Safety of EupentaTM InjStatus unknownNCT04056728Phase 4
• Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.Status unknownNCT04050098Phase 1
• A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaTerminatedNCT03970616Phase 1/2
• The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults.CompletedNCT03927677Phase 1
• BE Study of Bilayer Combination of Gemigliptin/Rosuvastatin 50/20mg in Comparison to Monolayer Combination.Status unknownNCT03867942Phase 1
• An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)CompletedNCT03864432Phase 1
• A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)CompletedNCT03842267Phase 3
• Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perlane in Nasolabial Fold InjectionCompletedNCT03738007Not applicable
• Gemigliptin, Dapagliflozin, Empagliflozin DDI StudyStatus unknownNCT03565458Phase 1
• A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy AdultsStatus unknownNCT03549208Phase 1
• Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802CompletedNCT03532854Phase 1
• A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy InfantsCompletedNCT03467984Phase 2
• BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered AloneCompletedNCT03355014Phase 1
• A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy AdultsCompletedNCT03208101Phase 1
• Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)CompletedNCT03202563Phase 4
• A Phase I Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetic Characteristics of LC28-0126.CompletedNCT03196804Phase 1
• A Study To Evaluate The Safety, Pharmacokinetics/Pharmacodynamics (PK/PD) and Food Effect Of LC51-0255CompletedNCT03174613Phase 1
• A Clinical Study to Evaluate the Safety and Immunogenicity of Inactivated Poliomyelitis Vaccine in Healthy InfantsCompletedNCT03169725Phase 2/3
• Relative Bioavailability Among Different Eutropin FormulationsStatus unknownNCT03154840Phase 1
• Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCCCompletedNCT03136627Phase 1/2
• To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®CompletedNCT03051087Phase 4
• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.CompletedNCT03015909Phase 4

← LG Chem overview and focus areas